1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2016

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2016" provides an overview of Adrenocortical Carcinoma (Adrenal Cortex Cancer) clinical trials scenario. This report provides top line data relating to the clinical trials on Adrenocortical Carcinoma (Adrenal Cortex Cancer). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials 26
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 80

List of Tables
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Region, 2016* 6
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 12
Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials, G7 Countries (%), 2016* 13
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials, E7 Countries (%), 2016* 16
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Phase, 2016* 19
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials, G7 Countries (%), 2016* 13
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Adrenocortical Carcinoma (Adrenal Cortex Cancer) to Oncology Clinical Trials, E7 Countries (%), 2016* 16
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 78

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the UK

  • November 2016
    10 pages
  • Cancer  

  • United Kingdom  

View report >

Cervical Cancer Statistics

  • November 2016
    6 pages
  • Cervical Cancer  

    Vaccine  

    HPV Vaccine  

View report >

Pollution Control Statistics in the US

  • November 2016
    218 pages
  • Pollution Contr...  

    Cancer  

    Metals  

  • United States  

    North America  

View report >

Related Market Segments :

Cancer
Clinical Trial
Therapy
Chemotherapy
Protein

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.